Immunax

ReGenMed

Your trusted biomedicine provider for almost two decades.

Contact us

What Do We Do?

Immunax (iMAP) is produced and distributed by Regenerative Medicine Co., Ltd. (ReGenMed). At ReGenMed we are transforming healthcare with advanced solutions in regenerative, integrative, and anti-aging medicine.


We serve medical professionals across Asia and around the world with cutting-edge technologies that enhance both physical and mental health. Our innovations are designed to advance patient care and clinical outcomes beyond the limits of conventional medicine.

Immunax Vial

Our Mission

Our mission is to empower physicians with innovative healthcare solutions that enhance patient outcomes. With cutting-edge regenerative medicine and a steadfast commitment to quality, we help medical professionals deliver exceptional care, giving patients the chance to live longer, healthier, and more fulfilling lives.

Our Vision

Our vision is to reshape the future of healthcare by making advanced regenerative and anti-aging therapies accessible to all. By empowering medical professionals with advanced solutions, we aim to redefine patient care and improve quality of life globally.

Our History

Founded in 2007 in Bangkok, Thailand, ReGenMed was born from a shared vision to push the boundaries of regenerative medicine. Our founding team of seasoned professionals was driven by an earnest desire to discover breakthrough technologies that elevate patient health and quality of life.

From our inception, we have continuously explored and vetted the latest advancements in medical science, ensuring that we deliver the most effective and cutting-edge products to our partners.

Our journey has been marked by relentless dedication to quality, safety, and excellence, earning us a trusted reputation in the industry. As we continue to innovate, we remain focused on delivering advanced solutions to healthcare providers worldwide.

Our Promise

We rigorously evaluate our products and competitors to ensure that we offer only the highest quality and most effective regenerative healthcare solutions. Prior to supplying any physician or medical clinic, all of our products go through an extensive due diligence process. 

Our manufacturing facilities, laboratories, and scientists are world-class and fully-audited under international regulatory standards. Our approach to product verification and quality control involves advanced genetic profiling, stringent sterility testing and in-depth analyses of product integrity and biological activity.

Sharing Our Experience With You

With almost 20 years of experience in the “Living Medicine” field, our team at ReGenMed is passionate about sharing our knowledge and insights. We are ready to serve as your research arm, helping you stay at the forefront of medical advancements and enabling you to embrace these transformative technologies. Together, let us embark on a journey towards optimal health and well-being for all.

For more information about Regenerative Medicine Co., Ltd. and other products available, please visit our website.

Click here

Our Team

With decades of experience in research and development of advanced healthcare solutions, our team at ReGenMed is dedicated to delivering high-quality innovative products to our partner physicians and clinics.

Brian Dardzinski M.Sc

Founder & Director

More Info

Jimmy Apichairuk

President & CEO

More Info

Brian Dardzinski M.Sc.

Founder and Director

Brian Dardzinski, M.Sc., is the founder and director of Regenerative Medicine Co., Ltd. With a dynamic 25-year career, Brian has assumed pivotal leadership roles in distinguished corporate organisations such as Tyco International and Thermo Fisher Scientific, showcasing exceptional expertise in healthcare and an unyielding thirst for knowledge, especially in the realm of new and advanced technologies.

As the global vice president of an adult stem cell company, Brian adeptly negotiated exclusive licensing distribution agreements, expanding operations globally. Serving as the VP of another stem cell company, he led a significant clinical trial at Chulalongkorn University in collaboration with the esteemed Queen Sirikit Center for Breast Cancer in Bangkok and participated in six other global trials.

In his 17-year tenure in Southeast Asia, Brian earned recognition for his profound contributions to advanced healthcare technologies and cell therapies. His exceptional performance as Senior Director of Research and Development at the world-renowned Bumrungrad International Hospital resulted in a promotion, placing him at the helm of their Integrative Wellness Center. Here, Brian not only spearheaded growth initiatives but also played a pivotal role in acquiring new technologies, showcasing his scientific acumen and deep understanding of biomedicines and technology, unmatched by few.

A distinguished graduate of Boston University with a Master of Science from San Jose State University, Brian’s unwavering passion for biotech research and breakthrough innovations propels his work. With unparalleled knowledge and expertise, he continues to shape the landscape of regenerative medicine in Asia and beyond.

Jimmy Apichairuk

President and CEO

Jimmy Apichairuk is a dynamic leader in the biotech industry, specializing in regenerative medicine and advanced anti-aging technologies. As the President & CEO of Regenerative Medicine Co., Ltd., he has successfully propelled cutting-edge treatments throughout South-East Asia and beyond. Jimmy’s charismatic personality, combined with his deep expertise and experience in regenerative medicine, positions him ideally to steer the company to global success.

Under Jimmy’s strategic leadership, the company introduced InfiNADi NAD+ Therapy, the world’s best-selling and most trusted NAD+ therapy, widely adopted in clinics and hospitals across the region. Jimmy’s marketing prowess and strategic acumen were pivotal in establishing InfiNADi as a leading choice and global market lead.

His dedication to healthcare and innovation and strategic approach are evident in his career achievements, including pivotal roles in renowned international stem cell companies. Under his guidance, these companies expanded globally, contributing to advancements in stem cell treatments and benefiting patients worldwide. Jimmy’s commitment to expanding biotechnology globally underscores his role as a visionary leader dedicated to improving healthcare outcomes globally.

Leveraging his degree in Health Administration from the University of Illinois and his time spent at Sasin Graduate School (MBA, Thailand), he continues to spearhead impactful initiatives at the intersection of health and business. He is driven by a profound passion for enhancing people’s lives and extending their healthspan.